HomeCompareAVGR vs KMB

AVGR vs KMB: Dividend Comparison 2026

AVGR yields 421.94% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AVGR wins by $182.7K in total portfolio value
10 years
AVGR
AVGR
● Live price
421.94%
Share price
$0.47
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$228.6K
Annual income
$477.83
Full AVGR calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.47
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,211.33
Full KMB calculator →

Portfolio growth — AVGR vs KMB

📍 AVGR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAVGRKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AVGR + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AVGR pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AVGR
Annual income on $10K today (after 15% tax)
$35,864.98/yr
After 10yr DRIP, annual income (after tax)
$406.16/yr
KMB
Annual income on $10K today (after 15% tax)
$445.84/yr
After 10yr DRIP, annual income (after tax)
$4,429.63/yr
At 15% tax rate, KMB beats the other by $4,023.48/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AVGR + KMB for your $10,000?

AVGR: 50%KMB: 50%
100% KMB50/50100% AVGR
Portfolio after 10yr
$137.2K
Annual income
$2,844.58/yr
Blended yield
2.07%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

AVGR
Analyst Ratings
4
Buy
3
Hold
Consensus: Buy
Altman Z
-48.2
Piotroski
4/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.5% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AVGR buys
0
KMB buys
6
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$KMB▼ Sell$1,001 - $15,0002025-11-12
Ro Khanna🏢 House$KMB▼ Sell$1,001 - $15,0002025-09-29
Ro Khanna🏢 House$KMB▼ Sell$1,001 - $15,0002025-09-05
Lisa McClain🏢 House$KMB▼ Sell$1,001 - $15,0002025-07-16
Lisa McClain🏢 House$KMB▲ Buy$1,001 - $15,0002025-07-10
Rob Bresnahan🏢 House$KMB▼ Sell$1,001 - $15,0002025-05-15
Rob Bresnahan🏢 House$KMB▼ Sell$1,001 - $15,0002025-04-08
Julie Johnson🏢 House$KMB▼ Sell$1,001 - $15,0002025-04-01
Ro Khanna🏢 House$KMB▲ Buy$1,001 - $15,0002024-11-15
Tommy Tuberville🏛 Senate$KMB▼ Sell$15,001 - $50,0002024-10-29
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAVGRKMB
Forward yield421.94%5.25%
Annual dividend / share$2.00$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%17%
Portfolio after 10y$228.6K$45.9K
Annual income after 10y$477.83$5,211.33
Total dividends collected$131.1K$21.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold

Year-by-year: AVGR vs KMB ($10,000, DRIP)

YearAVGR PortfolioAVGR Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$31,797$21,097.05$11,314$613.68+$20.5KAVGR
2$65,370$31,346.90$12,865$759.19+$52.5KAVGR
3$100,060$30,114.17$14,709$943.96+$85.4KAVGR
4$128,604$21,539.72$16,919$1,180.17+$111.7KAVGR
5$150,543$12,936.60$19,588$1,484.33+$131.0KAVGR
6$168,157$7,076.40$22,838$1,879.06+$145.3KAVGR
7$183,622$3,693.63$26,832$2,395.60+$156.8KAVGR
8$198,360$1,884.73$31,788$3,077.63+$166.6KAVGR
9$213,196$951.40$38,000$3,986.82+$175.2KAVGR
10$228,598$477.83$45,872$5,211.33+$182.7KAVGR

AVGR vs KMB: Complete Analysis 2026

AVGRStock

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was incorporated in 2007 and is headquartered in Redwood City, California.

Full AVGR Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this AVGR vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AVGR vs SCHDAVGR vs JEPIAVGR vs OAVGR vs KOAVGR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.